Cargando…

Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy

Reslizumab, an anti-interleukin-5 monoclonal antibody, significantly reduces exacerbation frequency and improves lung function, asthma control and quality of life in adults with severe eosinophilic asthma, as demonstrated in Phase III studies. This secondary analysis assessed reslizumab's effic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brusselle, Guy, Canvin, Janice, Weiss, Sivan, Sun, Shawn X., Buhl, Roland
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570512/ https://www.ncbi.nlm.nih.gov/pubmed/28845430 http://dx.doi.org/10.1183/23120541.00004-2017

Ejemplares similares

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?
por: Varricchi, Gilda, et al.
Publicado: (2017)

Role of biologics in severe eosinophilic asthma – focus on reslizumab
por: Pelaia, Girolamo, et al.
Publicado: (2016)

Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Reslizumab: Spanish Real-Life Data
por: Pérez de Llano, Luis A, et al.
Publicado: (2022)

Update on new biologics for intractable eosinophilic asthma: impact of reslizumab
por: Sahota, Jagdeep, et al.
Publicado: (2018)

Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma
por: Walsh, Garry M
Publicado: (2013)

Successful treatment of refractory eosinophilic fasciitis with reslizumab
por: Mortezavi, Mahta, et al.
Publicado: (2020)

Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
por: Levy, Mark L., et al.
Publicado: (2023)

Reslizumab as add-on therapy in patients with refractory asthma
por: Virchow, J Christian, et al.
Publicado: (2020)

Prevalence of Patients with Uncontrolled Asthma Despite NVL/GINA Step 4/5 Treatment in Germany
por: Bergmann, Karl-Christian, et al.
Publicado: (2022)

Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
por: Kent, Brian D., et al.
Publicado: (2020)

Reslizumab in the treatment of inadequately controlled asthma in adults and adolescents with elevated blood eosinophils: clinical trial evidence and future prospects
por: Máspero, Jorge
Publicado: (2017)

Reslizumab in the management of poorly controlled asthma: the data so far
por: Maselli, Diego Jose, et al.
Publicado: (2016)

Diagnosis and management of asthma – Statement on the 2015 GINA Guidelines
por: Horak, Fritz, et al.
Publicado: (2016)

Non-episodic Angioedema With Eosinophilia Successfully Treated With Reslizumab
por: Chu, Hyunwook, et al.
Publicado: (2019)

The effectiveness of Reslizumab in severe asthma treatment: a real-world experience
por: Ibrahim, H., et al.
Publicado: (2019)

The GINA asthma strategy report: what’s new for primary care?
por: Reddel, Helen K, et al.
Publicado: (2015)

In patients with severe asthma with eosinophilia in reslizumab clinical trials, high peripheral blood eosinophil levels are associated with low FEV(1) reversibility
por: Virchow, J. Christian, et al.
Publicado: (2020)

Two cheers for GINA?
por: McGuire, Amy L, et al.
Publicado: (2009)

A summary of the new GINA strategy: a roadmap to asthma control
por: Reddel, Helen K., et al.
Publicado: (2015)

Implementation of GINA guidelines in asthma management by primary care physicians in Vietnam
por: Nguyen, Vinh Nhu, et al.
Publicado: (2017)

Health Care Situation in the Treatment of Uncontrolled GINA Step 4/5 Patients in Germany
por: Timmermann, Hartmut, et al.
Publicado: (2023)

Asthma in pregnancy: association of asthma control test (ACT) with clinical management by the global initiative for asthma (GINA)
por: Araujo, Georgia, et al.
Publicado: (2015)

Real-World clinical outcomes of asthma patients switched from reslizumab to mepolizumab or benralizumab
por: Walsh, Laura J., et al.
Publicado: (2023)

The correlation between the bronchial hyperresponsiveness to methacholine and asthma like symptoms by GINA questionnaires for the diagnosis of asthma
por: Lim, So Yeon, et al.
Publicado: (2014)

Are the Global Initiative for Asthma (GINA) Guidelines Being Correctly Used to Diagnose Severe Asthma in the UAE?
por: Abuzakouk, Mohamed, et al.
Publicado: (2020)

Classification of asthma according to revised 2006 GINA: Evolution from severity to control
por: Koshak, Emad A.
Publicado: (2007)

It is time to change the way we manage mild asthma: an update in GINA 2019
por: Muneswarao, Jaya, et al.
Publicado: (2019)

New approach to intermittent and mild asthma therapy: evolution or revolution in the GINA guidelines?
por: Kuprys-Lipinska, Izabela, et al.
Publicado: (2020)

Section 1. EPR-3 versus GINA 2008 Guidelines - Asthma Control and Step 3 Care: Highlights of the Asthma Summit 2009: Beyond the Guidelines
por: Bousquet, Jean, et al.
Publicado: (2010)

Gina DeNicola: In vivo veritas
por: Morgado-Palacin, Lucia
Publicado: (2023)

ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy
por: Cruz, Álvaro A., et al.
Publicado: (2021)

Refractory Bullous Pemphigoid Successfully Treated with Reslizumab: A Possible Novel Therapeutic Modality
por: Kwon, Hyeok-Jin, et al.
Publicado: (2023)

A systematic review with attempted network meta-analysis of asthma therapy recommended for five to eighteen year olds in GINA steps three and four
por: van der Mark, Lonneke B, et al.
Publicado: (2012)

Disparate impacts and GINA: Congress's unfinished business
por: Wagner, Jennifer K
Publicado: (2019)

Characteristics of Oral Corticosteroid Users Among Persons with Asthma on GINA Step 3 Therapy and Above: A Cross-Sectional Study in Portuguese Community Pharmacies
por: Romão, Mariana, et al.
Publicado: (2022)

Nonepisodic angioedema with eosinophilia after COVID-19 vaccination: a case successfully treated with reslizumab
por: Nam, Young-Hee
Publicado: (2023)

Combination of Fractional Exhaled Nitric Oxide (FeNO) Level and Asthma Control Test (ACT) in Detecting GINA-Defined Asthma Control in Treated Asthmatic Patients in Vietnam
por: Nguyen Nhu, Vinh, et al.
Publicado: (2020)

Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives
por: Padilla Galo, Alicia, et al.
Publicado: (2018)

Anaphylactic risk related to omalizumab, benralizumab, reslizumab, mepolizumab, and dupilumab
por: Li, Lisha, et al.
Publicado: (2021)

Higher Binding Affinity and In Vitro Potency of Reslizumab for Interleukin-5 Compared With Mepolizumab
por: Liddament, Mark, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m3vbe3j4v4n64g9cmslhfbji26